
Regencell Bioscience Investors Urged to Join Securities Fraud Class Action
Investors who incurred significant financial losses holding Regencell Bioscience Holdings Limited shares have until June 23, 2026, to file as lead plaintiffs in a pending securities fraud lawsuit. The Law Offices of Howard G. Smith is currently organizing the class action following allegations of market manipulation and misleading corporate disclosures.


























